Trilogy Capital’s iShares Core S&P US Value ETF IUSV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Sell
2,294
-299
-12% -$32.4K 0.01% 360
2026
Q1
$265K Buy
2,593
+337
+15% +$35.3K 0.01% 343
2025
Q4
$231K Sell
2,256
-21
-0.9% -$2.13K 0.01% 360
2025
Q3
$228K Sell
2,277
-455
-17% -$44.3K 0.01% 356
2025
Q2
$259K Buy
2,732
+4
+0.1% +$361 0.01% 318
2025
Q1
$252K Buy
2,728
+1
+0% +$94 0.01% 305
2024
Q4
$252K Buy
2,727
+440
+19% +$42.3K 0.01% 300
2024
Q3
$218K Buy
+2,287
New +$210K 0.01% 309
2021
Q2
Sell
-6,299
Closed -$434K 171
2021
Q1
$434K Buy
+6,299
New +$413K 0.03% 129
2018
Q4
Sell
-115
Closed -$6K 347
2018
Q3
$6K Hold
115
﹤0.01% 376
2018
Q2
$6K Hold
115
﹤0.01% 347
2018
Q1
$6K Buy
+115
New +$6.37K ﹤0.01% 298

Other funds holding IUSV

Trilogy Capital's IUSV Position: Q2 2026 in Review

Trilogy Capital reduced its iShares Core S&P US Value ETF (IUSV) stake by 12% in Q2 2026, selling an estimated $32.4K and leaving 2,294 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #360.

Trilogy Capital first reported a position in IUSV in Q1 2018 and has held it in 12 quarters since. The position peaked at $434K in Q1 2021. 127 funds tracked by Wall St. Rank hold IUSV as of Q2 2026.

  • Trilogy Capital held 2,294 shares of iShares Core S&P US Value ETF worth $253K as of Q2 2026.
  • Trilogy Capital sold 299 iShares Core S&P US Value ETF shares in Q2 2026, an estimated $32.4K.
  • iShares Core S&P US Value ETF made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #360 holding.
  • Trilogy Capital first reported a position in iShares Core S&P US Value ETF in Q1 2018 and has held it in 12 quarters since.
  • Trilogy Capital's iShares Core S&P US Value ETF position peaked at $434K in Q1 2021.
  • 127 funds tracked by Wall St. Rank held iShares Core S&P US Value ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.